SP1 and gastric cancer: In their study, Mao et al. (2023) demonstrated that Pleckstrin-2 in gastric cancer can enhance the expression of MT1-MMPs through the PI3K-AKT-Sp1 signaling pathway, resulting in the release of MICA and subsequently impairing NK cell-mediated immune surveillance, thereby facilitating tumor progression.